DK1363930T3 - En fremgangsmåde til fremstilling af genetiske ændrede antigener - Google Patents

En fremgangsmåde til fremstilling af genetiske ændrede antigener

Info

Publication number
DK1363930T3
DK1363930T3 DK00978578T DK00978578T DK1363930T3 DK 1363930 T3 DK1363930 T3 DK 1363930T3 DK 00978578 T DK00978578 T DK 00978578T DK 00978578 T DK00978578 T DK 00978578T DK 1363930 T3 DK1363930 T3 DK 1363930T3
Authority
DK
Denmark
Prior art keywords
useful
genes
methods
cells
genetically altered
Prior art date
Application number
DK00978578T
Other languages
English (en)
Inventor
Luigi Grasso
Nicholas C Nicolaides
Philip M Sass
Original Assignee
Morphotek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphotek Inc filed Critical Morphotek Inc
Application granted granted Critical
Publication of DK1363930T3 publication Critical patent/DK1363930T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK00978578T 2000-11-14 2000-11-14 En fremgangsmåde til fremstilling af genetiske ændrede antigener DK1363930T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/031135 WO2002040499A1 (en) 2000-11-14 2000-11-14 A method for generating genetically altered antigens

Publications (1)

Publication Number Publication Date
DK1363930T3 true DK1363930T3 (da) 2006-09-04

Family

ID=21741992

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00978578T DK1363930T3 (da) 2000-11-14 2000-11-14 En fremgangsmåde til fremstilling af genetiske ændrede antigener

Country Status (8)

Country Link
EP (1) EP1363930B1 (da)
JP (1) JP2005509399A (da)
AT (1) ATE336505T1 (da)
AU (1) AU2001216030A1 (da)
CA (1) CA2429134C (da)
DE (1) DE60030172T2 (da)
DK (1) DK1363930T3 (da)
WO (1) WO2002040499A1 (da)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5917017A (en) * 1994-06-08 1999-06-29 President And Fellows Of Harvard College Diphtheria toxin vaccines bearing a mutated R domain
RU2201451C2 (ru) * 1994-06-17 2003-03-27 Инститют Вор Дирхаудерей эн Диргезондхейд Нуклеотидная последовательность вируса классической свиной лихорадки (csfv) (варианты), полипептид csfv, пестивирусная вакцина против csfv, диагностический набор и способ
PT773957E (pt) * 1994-07-29 2005-11-30 Chiron Corp Polipeptidos truncados e1 e e2 de hepatite c inovadores, e metodos de obtencao dos mesmos
US5612030A (en) * 1995-01-17 1997-03-18 University Of Kentucky Research Foundation Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5843757A (en) * 1995-08-24 1998-12-01 The Johns Hopkins University Human JTV1 gene overlaps PMS2 gene
KR20010022452A (ko) * 1997-07-31 2001-03-15 추후제출 플라비바이러스 감염에 대한 재조합 다이머형 엔벨롭 백신
US6146894A (en) * 1998-04-14 2000-11-14 The Johns Hopkins University Method for generating hypermutable organisms

Also Published As

Publication number Publication date
EP1363930A4 (en) 2004-04-14
DE60030172T2 (de) 2007-07-05
CA2429134C (en) 2011-03-15
JP2005509399A (ja) 2005-04-14
AU2001216030A1 (en) 2002-05-27
WO2002040499A1 (en) 2002-05-23
ATE336505T1 (de) 2006-09-15
DE60030172D1 (de) 2006-09-28
EP1363930A1 (en) 2003-11-26
EP1363930B1 (en) 2006-08-16
CA2429134A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
CA2240609A1 (en) A method for generating hypermutable organisms
WO2004024871A3 (en) Antibodies and methods for generating genetically altered antibodies with high affinity
TWI255853B (en) Method for modifying chromosomes
AU2003303831A1 (en) Vaccine production using transposon based vectors
AR044246A1 (es) Vectores y celulas para la preparacion de composiciones inmunoprotectoras derivadas de plantas transgenicas
AU2003210405A1 (en) Inbred embryonic stem-cell derived mice
DE69533964D1 (de) Orale immunisierung durch verwendung von transgenen pflanzen
SG41951A1 (en) Isolation selection and propagation of animal stem cells genetically modified animals and animals cells and constructs for their production
DK1391511T3 (da) Humant kunstigt kromosom indeholdende human antistof lambda-let-kæde-gen
TW200510529A (en) Methods for the production of insulin in plants
HK1083635A1 (en) Animal protein free media for cultivation of cells
IL166771A0 (en) Method for producing ketocarotinoids in genetically modified organisms
DK1159415T3 (da) Genetisk modifikation af somatiske celler og anvendelse deraf
HUP9900885A2 (hu) Hímsterilitás indukálása növényekben avidin nagy mennyiségben történő expresszálásával
EP1534066A4 (en) CELLS WITHOUT ALPHA (1,3) -GALACTOSYLTRANSFERASE, METHODS OF SELECTION, AND PORK HAVING ALPHA (1,3) -GALACTOSYLTRANSFERASE THUS OBTAINED
ATE455179T1 (de) Humanes chromosomfragment und ein vektor, der dies enthält
WO2001088192A3 (en) A method for generating hypermutable organisms
DE60144247D1 (de) Chemische hemmstoffe des mismatch-repair
CN105850747B (zh) 一种多肉植物虹之玉的组织快速繁殖方法及其培养的虹之玉
DK1363930T3 (da) En fremgangsmåde til fremstilling af genetiske ændrede antigener
ATE443762T1 (de) Induktierbare transposition beim transgenen organismus mit transposon-vektor
CN109722436A (zh) 基于CRISPR-Cas9的基因组无痕编辑的载体与应用
Mashkina et al. Field trials of in vitro propagated aspen clones (Populus tremula L.): growth, productivity, wood quality, and genetic stability
DE60335129D1 (de) VERFAHREN ZUR ERZEUGUNG VERBESSERTER ANTIKöRPER PRODUZIERENDER ZELLINIEN MIT VERBESSERTEN WACHSTUMSEIGENSCHAFTEN
DK1554374T3 (da) Fremgangsmåde til storskala T-lymfocytdyrkning i et homogent system